"The Bioasis xB3 patented platform provides researchers with a solution to one of medicine’s most stubborn challenges: how to transport medicines across the blood-brain barrier at doses sufficient to have a therapeutic effect."
Börse | | | Hot-Stocks | | | Talk |
Bioasis Technologies: blood-brain barrier (BBB) |
|
Posting: 1 Zugriffe: 157 / Heute: 0 |
BIOASIS TECHNOL.: | 0,199 € | -1,49% |
Perf. seit Threadbeginn: | -39,69% |